155 related articles for article (PubMed ID: 27733010)
21. Traumatic brain injury and β-blockers: not all drugs are created equal.
Schroeppel TJ; Sharpe JP; Magnotti LJ; Weinberg JA; Clement LP; Croce MA; Fabian TC
J Trauma Acute Care Surg; 2014 Feb; 76(2):504-9; discussion 509. PubMed ID: 24458058
[TBL] [Abstract][Full Text] [Related]
22. The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea.
Kim C; Lee HS; Min CK; Lee JJ; Kim K; Yoon DH; Eom HS; Lee H; Lee WS; Shin HJ; Lee JH; Park Y; Jo JC; Do YR; Mun YC
Korean J Intern Med; 2015 Sep; 30(5):675-83. PubMed ID: 26354062
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management.
Nabeta T; Inomata T; Iida Y; Ikeda Y; Iwamoto-Ishida M; Ishii S; Naruke T; Mizutani T; Shinagawa H; Koitabashi T; Takeuchi I; Ako J
Heart Vessels; 2016 Jul; 31(7):1109-16. PubMed ID: 26253941
[TBL] [Abstract][Full Text] [Related]
24. β-Blockers, Pneumonia, and Outcome After Ischemic Stroke: Evidence From Virtual International Stroke Trials Archive.
Sykora M; Siarnik P; Diedler J;
Stroke; 2015 May; 46(5):1269-74. PubMed ID: 25899243
[TBL] [Abstract][Full Text] [Related]
25. The impact of beta-blocker therapy on anemia after traumatic brain injury.
Glass NE; Kaltenbach LA; Fleming SB; Arbogast PG; Cotton BA
Transfusion; 2012 Oct; 52(10):2155-60. PubMed ID: 22420303
[TBL] [Abstract][Full Text] [Related]
26. Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational, Retrospective, Cohort Study.
Kistler KD; Kalman J; Sahni G; Murphy B; Werther W; Rajangam K; Chari A
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):89-96.e3. PubMed ID: 28025038
[TBL] [Abstract][Full Text] [Related]
27. Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma.
Mian I; Milton DR; Shah N; Nieto Y; Popat UR; Kebriaei P; Parmar S; Oran B; Shah JJ; Manasanch EE; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH; Bashir Q
Cancer; 2016 Dec; 122(24):3831-3837. PubMed ID: 27680710
[TBL] [Abstract][Full Text] [Related]
28. Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma.
Udumyan R; Montgomery S; Fang F; Almroth H; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
Cancer Res; 2017 Jul; 77(13):3700-3707. PubMed ID: 28473530
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R
PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836
[TBL] [Abstract][Full Text] [Related]
30. Novel agents have a significant impact on survival of patients with multiple myeloma.
Lamm W; Eder S; Bojic M; Zielinski CC; Drach J
Wien Klin Wochenschr; 2015 Feb; 127(3-4):92-7. PubMed ID: 25609569
[TBL] [Abstract][Full Text] [Related]
31. Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
Mateos MV; Dimopoulos MA; Cavo M; Suzuki K; Jakubowiak A; Knop S; Doyen C; Lucio P; Nagy Z; Kaplan P; Pour L; Cook M; Grosicki S; Crepaldi A; Liberati AM; Campbell P; Shelekhova T; Yoon SS; Iosava G; Fujisaki T; Garg M; Chiu C; Wang J; Carson R; Crist W; Deraedt W; Nguyen H; Qi M; San-Miguel J;
N Engl J Med; 2018 Feb; 378(6):518-528. PubMed ID: 29231133
[TBL] [Abstract][Full Text] [Related]
32. Perioperative beta blockers and statins for noncardiac surgery patients with coronary stents.
Richman JS; Graham LA; DeRussy A; Maddox TM; Itani KMF; Hawn MT
Am J Surg; 2017 Aug; 214(2):180-185. PubMed ID: 28641862
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of results of drug therapy for symptomatic multiple myeloma].
Lysenko LB; Nikolaeva N; Pushkareva TF; Kapuza EA; Shatokhina ON; Kozyuk OV; Dmitrieva VV; Snezhko TA; Novoselova KA
Vopr Onkol; 2015; 61(4):667-70. PubMed ID: 26571842
[TBL] [Abstract][Full Text] [Related]
34. β-Blocker-Associated Risks in Patients With Uncomplicated Hypertension Undergoing Noncardiac Surgery.
Jørgensen ME; Hlatky MA; Køber L; Sanders RD; Torp-Pedersen C; Gislason GH; Jensen PF; Andersson C
JAMA Intern Med; 2015 Dec; 175(12):1923-31. PubMed ID: 26436291
[TBL] [Abstract][Full Text] [Related]
35. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients.
Sampat U; Varadarajan P; Turk R; Kamath A; Khandhar S; Pai RG
J Am Coll Cardiol; 2009 Jul; 54(5):452-7. PubMed ID: 19628121
[TBL] [Abstract][Full Text] [Related]
36. Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.
Cresci S; Jones PG; Sucharov CC; Marsh S; Lanfear DE; Garsa A; Courtois M; Weinheimer CJ; Wu J; Province MA; Kelly DP; McLeod HL; Spertus JA
Pharmacogenomics; 2008 Oct; 9(10):1403-17. PubMed ID: 18855529
[TBL] [Abstract][Full Text] [Related]
37. Β-blockers treatment of cardiac surgery patients enhances isolation and improves phenotype of cardiosphere-derived cells.
Chimenti I; Pagano F; Cavarretta E; Angelini F; Peruzzi M; Barretta A; Greco E; De Falco E; Marullo AG; Sciarretta S; Biondi-Zoccai G; Frati G
Sci Rep; 2016 Nov; 6():36774. PubMed ID: 27841293
[TBL] [Abstract][Full Text] [Related]
38. A cutoff point for peak oxygen consumption in the prognosis of heart failure patients with β-blocker therapy.
Guimaraes GV; d'Avila VM; Silva MS; Ferreira SA; Ciolac EG; Carvalho VO; Bocchi EA
Int J Cardiol; 2010 Nov; 145(1):75-7. PubMed ID: 19477026
[TBL] [Abstract][Full Text] [Related]
39. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.
Lamb DA; Eurich DT; McAlister FA; Tsuyuki RT; Semchuk WM; Wilson TW; Blackburn DF
Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):228-35. PubMed ID: 20031842
[TBL] [Abstract][Full Text] [Related]
40. Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer.
Fukada I; Araki K; Kobayashi K; Shibayama T; Takahashi S; Gomi N; Kokubu Y; Oikado K; Horii R; Akiyama F; Iwase T; Ohno S; Hatake K; Sata N; Ito Y
Radiology; 2018 Jan; 286(1):49-57. PubMed ID: 28737968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
